Sort   by:  
 Page size 
ProteomicsProteomics-based approach reveals the involvement of SERPINB9 in recurrent and relapsed multiple myeloma
Multiple myeloma (MM) is a common hematological malignancy with poorly understood recurrence and relapse mechanisms. Notably, bortezomib resistance leading to relapse makes MM treatment significantly challenging. To clarify the drug resistance mechanism, we employed a quantitative proteomics approac...
ORGANISM(S): Homo sapiens (Human) 
2021-03-03 | PXD022182 | Pride
Multiple myeloma  recurrence and relapse  proteomics  parallel reaction monitoring  serpinb9 
ProteomicsPancreatic cancer Serpinb9（KD VS NC) proteomics
This study investigates the proteomic alterations in pancreatic cancer cells resulting from Serpinb9 knockdown (KD) compared to normal control (NC). Two experimental groups, each consisting of three biological replicates, were analyzed to identify key proteins and pathways associated with Serpinb9's...
ORGANISM(S): Mus musculus (Mouse) 
2025-09-01 | PXD059411 | Pride
Serpinb9 Pancreatic cancer Knockdown 
UnknownSERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response.
Not available
S-EPMC9710519 | biostudies-literature
UnknownSingle-cell landscape identified SERPINB9 as a key player contributing to stemness and metastasis in non-seminomas.
Not available
S-EPMC11555415 | biostudies-literature
TranscriptomicsSERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response
After exposing a panel of non-small cell lung cancer (NSCLC) cell lines to cytotoxic CD8+ T-cells, we found SERPINB9 to be the most differentially expressed gene between the cell lines most and least resistant to T-cell killing.
ORGANISM(S): Homo sapiens 
2022-10-12 | GSE214992 | GEO
UnknownDisrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.
Not available
S-EPMC6693965 | biostudies-literature
GenomicsSERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response
SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response
PRJNA888044 | ENA
UnknownDirect Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.
Not available
S-EPMC7927154 | biostudies-literature
UnknownDecreased GZMB, NRP1, ITPR1, and SERPINB9 Transcripts Lead to Reduced Regulatory T Cells Suppressive Capacity in Generalized Vitiligo Patients.
Not available
S-EPMC9500245 | biostudies-literature
ProteomicsProteomics-Based Approach Reveals the Involvement of Spliceosomal Components SF3B and SerpinB9 in Dermatofibrosarcoma Protuberance
Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous soft tissue sarcoma which prone to high recurrence rate, especially the high grade sub-type. We applied label-free proteomics quantification to profile the molecular signatures of DFSP tumors in contrast to adjacent normal tissues.
ORGANISM(S): Homo sapiens (Human) 
2026-09-09 | PXD074336 | Pride
Dermatofibrosarcoma protuberance Sf3b Serpinb9 
Sort   by:  
 Page size